Editing Sexual dysfunction (section)

=== With SSRI medication ===

Sexual problems are common with SSRIs,<ref>{{cite journal | vauthors = Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K | title = Strategies for managing sexual dysfunction induced by antidepressant medication | journal = The Cochrane Database of Systematic Reviews | volume = 5 | issue = 5 | pages = CD003382 | date = May 2013 | pmid = 23728643 | doi = 10.1002/14651858.CD003382.pub3 | doi-access = free }}</ref> which can cause [[anorgasmia]], [[erectile dysfunction]], diminished [[libido]], genital numbness, and [[sexual anhedonia]] (pleasureless orgasm).<ref name="Bahrick">{{cite journal| vauthors = Bahrick AS |year=2008|title=Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence|url=https://benthamopen.com/ABSTRACT/TOPSYJ-1-42|journal=The Open Psychology Journal|volume=1|pages=42–50|doi=10.2174/1874350100801010042|doi-access=free}}</ref>  Poor sexual function is also one of the most common reasons people stop the medication.<ref>{{cite journal | vauthors = Kennedy SH, Rizvi S | title = Sexual dysfunction, depression, and the impact of antidepressants | journal = Journal of Clinical Psychopharmacology | volume = 29 | issue = 2 | pages = 157–164 | date = April 2009 | pmid = 19512977 | doi = 10.1097/jcp.0b013e31819c76e9 | s2cid = 739831 }}</ref> In some cases, symptoms of sexual dysfunction may persist after discontinuation of SSRIs.<ref name="Bahrick" /><ref>{{Cite book|title=Neurology of Sexual and Bladder Disorders|vauthors=Waldinger MD|year=2015|isbn=978-0-444-63247-0|series=Handbook of Clinical Neurology|volume=130|pages=479–83|chapter=Psychiatric disorders and sexual dysfunction|doi=10.1016/B978-0-444-63247-0.00027-4|pmid=26003261}}</ref><ref name="Prozac_Insert">{{cite web|url=http://pi.lilly.com/us/prozac.pdf|title=Prozac Highlights of Prescribing Information|date=24 March 2017|publisher=Eli Lilly and Company}}</ref>{{rp|14}}<ref name=":3">{{cite journal | vauthors = Reisman Y | title = Sexual Consequences of Post-SSRI Syndrome | journal = Sexual Medicine Reviews | volume = 5 | issue = 4 | pages = 429–433 | date = October 2017 | pmid = 28642048 | doi = 10.1016/j.sxmr.2017.05.002 | quote = Initial SSRI registration studies found that such side effects were reported by fewer than 10% of patients.  When doctors specifically asked about treatment-emergent sexual difficulties, some found that they were present in up to 70% of patients. }}</ref><ref name="DSM5">{{cite book | author=American Psychiatric Association|year=2013|title=Diagnostic and Statistical Manual of Mental Disorders | edition = 5th |location=Arlington|publisher=American Psychiatric Publishing|pages=449|isbn=978-0-89042-555-8 }}</ref> This combination of symptoms is sometimes referred to as [[Selective serotonin reuptake inhibitor#Sexual dysfunction|post-SSRI sexual dysfunction]].<ref name=":4">{{cite journal | vauthors = Healy D | title = Post-SSRI sexual dysfunction & other enduring sexual dysfunctions | journal = Epidemiology and Psychiatric Sciences | volume = 29 | pages = e55 | date = September 2019 | pmid = 31543091 | pmc = 8061302 | doi = 10.1017/S2045796019000519 | quote = Close to 100% of takers of a selective serotonin reuptake inhibitor (SSRI) have a degree of genital sensory change within 30 min of taking. | doi-access = free }}</ref><ref name=":2">{{Cite journal| vauthors = Bahrick AS |date=2006|title=Post SSRI sexual dysfunction|url=https://www.researchgate.net/publication/236587031|journal=American Society for the Advancement of Pharmacotherapy|volume=Tablet 7.3|pages=2–3}}</ref>